We hypothesized that BDMC reverse intrinsic icotinib resistance in NSCLC cells with EGFR wild-type and K-ras mutation or Her 2 mutation through induction of autophagy-related cell death and apoptosis. This evidence concerns the gene KRAS and non-small cell lung carcinoma.